Sector Gamma AS’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-102,490
| Closed | -$4.9M | – | 32 |
|
2023
Q4 | $4.9M | Sell |
102,490
-12,676
| -11% | -$606K | 1.19% | 27 |
|
2023
Q3 | $4.11M | Buy |
115,166
+14,561
| +14% | +$519K | 1.05% | 22 |
|
2023
Q2 | $4.64M | Sell |
100,605
-5,677
| -5% | -$262K | 1.04% | 25 |
|
2023
Q1 | $4.26M | Buy |
106,282
+60,762
| +133% | +$2.44M | 1.03% | 27 |
|
2022
Q4 | $2.11M | Hold |
45,520
| – | – | 0.48% | 31 |
|
2022
Q3 | $1.89M | Sell |
45,520
-701
| -2% | -$29K | 0.49% | 26 |
|
2022
Q2 | $2.76M | Hold |
46,221
| – | – | 0.62% | 31 |
|
2022
Q1 | $3.36M | Buy |
+46,221
| New | +$3.36M | 0.73% | 32 |
|
2020
Q3 | – | Sell |
-108,734
| Closed | -$8.51M | – | 33 |
|
2020
Q2 | $8.51M | Sell |
108,734
-36,338
| -25% | -$2.84M | 1.76% | 23 |
|
2020
Q1 | $6.45M | Sell |
145,072
-70,124
| -33% | -$3.12M | 1.37% | 26 |
|
2019
Q4 | $9.19M | Buy |
215,196
+42,218
| +24% | +$1.8M | 1.47% | 26 |
|
2019
Q3 | $7.4M | Buy |
172,978
+93,325
| +117% | +$3.99M | 1.25% | 29 |
|
2019
Q2 | $5.06M | Buy |
79,653
+13,718
| +21% | +$871K | 0.81% | 33 |
|
2019
Q1 | $4.57M | Buy |
65,935
+57,935
| +724% | +$4.02M | 0.73% | 29 |
|
2018
Q4 | $348K | Sell |
8,000
-21,368
| -73% | -$930K | 0.06% | 33 |
|
2018
Q3 | $2.24M | Sell |
29,368
-38,647
| -57% | -$2.95M | 0.35% | 29 |
|
2018
Q2 | $5.23M | Buy |
+68,015
| New | +$5.23M | 0.87% | 26 |
|